Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 43351-43360 Newer>

The Motley Fool August 17, 2010 Travers & Jayson	How Long Can Amylin Pharmaceuticals Last? You don't need an advanced degree in pharmacology to find biotech companies with a legitimate chance of hitting it big.
The Motley Fool August 17, 2010 Eric Jhonsa	Waiting for an iPad Killer? Don't Hold Your Breath. Rival tablets might be cheaper than the iPad, but they won't be better.
The Motley Fool August 17, 2010 David Meier	Guess?: Deflation Fighter Guess? could be a good candidate to keep you ahead of the game.
The Motley Fool August 17, 2010 Anders Bylund	Agilent Made All the Right Moves Cut the dead weight and refocus on attractive markets? Sounds like a plan to me.
The Motley Fool August 17, 2010 Travers & Jayson	Is Alexion Pharmaceuticals Burning Out? The first step toward finding a promising biotech company is not to figure out whether the science is any good, but to make sure that the company is financially healthy.
The Motley Fool August 17, 2010 Jeremy Phillips	Why Investors Are Shorting Cree Does this highly shorted stock deserve it?
InternetNews August 17, 2010	Wall Street Hopes Salesforce Stays Hot The on-demand CRM and business applications provider is trading at a rarefied price and, thus far, its sales and earnings have justified the lofty valuation.
The Motley Fool August 17, 2010 Michael Olsen	These Stocks Could Lose Your Money Their business model just doesn't make sense. When times turn tough, exploration and production companies structured as master limited partnerships fit that bill, sadly.
The Motley Fool August 17, 2010 Alyce Lomax	These Stocks Could Be Homewreckers Home Depot and Lowe's most recent quarterly results should prompt caution, not bullishness, among investors.
The Motley Fool August 17, 2010 David Meier	MasterCard: Deflation Fighter Cash-rich companies with very little debt burden seem like a great place to start looking for ideas during deflationary periods, and right now, MasterCard looks like a deflation fighter.
<Older 43351-43360 Newer> Return to current articles.